JP4934293B2 - Plant vitality composition - Google Patents
Plant vitality composition Download PDFInfo
- Publication number
- JP4934293B2 JP4934293B2 JP2005195942A JP2005195942A JP4934293B2 JP 4934293 B2 JP4934293 B2 JP 4934293B2 JP 2005195942 A JP2005195942 A JP 2005195942A JP 2005195942 A JP2005195942 A JP 2005195942A JP 4934293 B2 JP4934293 B2 JP 4934293B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- acid
- aromatic
- aminolevulinic acid
- butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 12
- 229960002749 aminolevulinic acid Drugs 0.000 claims description 28
- 125000003118 aryl group Chemical group 0.000 claims description 27
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 claims description 11
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 125000004423 acyloxy group Chemical group 0.000 claims description 7
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 125000001153 fluoro group Chemical group F* 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 125000004043 oxo group Chemical group O=* 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- -1 5-aminolevulinic acid ester sulfonic acid salt Chemical class 0.000 description 115
- 125000004432 carbon atom Chemical group C* 0.000 description 19
- 125000000217 alkyl group Chemical group 0.000 description 15
- 241000196324 Embryophyta Species 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 125000003710 aryl alkyl group Chemical group 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 6
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 6
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- 125000003342 alkenyl group Chemical group 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 3
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 125000005917 3-methylpentyl group Chemical group 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000032 diagnostic agent Substances 0.000 description 3
- 229940039227 diagnostic agent Drugs 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000002428 photodynamic therapy Methods 0.000 description 3
- 150000003460 sulfonic acids Chemical class 0.000 description 3
- 125000006702 (C1-C18) alkyl group Chemical group 0.000 description 2
- 125000006736 (C6-C20) aryl group Chemical group 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- DMSRJJQJLOCKOW-UHFFFAOYSA-N 5-amino-4-oxopentanoic acid;4-methylbenzenesulfonic acid Chemical compound NCC(=O)CCC(O)=O.CC1=CC=C(S(O)(=O)=O)C=C1 DMSRJJQJLOCKOW-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 125000006606 n-butoxy group Chemical group 0.000 description 2
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 239000005962 plant activator Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- NUMQCACRALPSHD-UHFFFAOYSA-N tert-butyl ethyl ether Chemical compound CCOC(C)(C)C NUMQCACRALPSHD-UHFFFAOYSA-N 0.000 description 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- PCTZLSCYMRXUGW-UHFFFAOYSA-N 1,1,1,2,2-pentafluorobutane Chemical group [CH2]CC(F)(F)C(F)(F)F PCTZLSCYMRXUGW-UHFFFAOYSA-N 0.000 description 1
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- NLUGCAKOZAODBF-UHFFFAOYSA-N 1-pentylsulfonylpentane Chemical compound CCCCCS(=O)(=O)CCCCC NLUGCAKOZAODBF-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- OZARAEFTGONNJV-UHFFFAOYSA-N 2,2-dimethylpropane-1-sulfonic acid Chemical compound CC(C)(C)CS(O)(=O)=O OZARAEFTGONNJV-UHFFFAOYSA-N 0.000 description 1
- CHZLVSBMXZSPNN-UHFFFAOYSA-N 2,4-dimethylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C(C)=C1 CHZLVSBMXZSPNN-UHFFFAOYSA-N 0.000 description 1
- IRLYGRLEBKCYPY-UHFFFAOYSA-N 2,5-dimethylbenzenesulfonic acid Chemical compound CC1=CC=C(C)C(S(O)(=O)=O)=C1 IRLYGRLEBKCYPY-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- DHIXFTVGHROZHD-UHFFFAOYSA-N 2-ethylhexane-1-sulfonic acid Chemical compound CCCCC(CC)CS(O)(=O)=O DHIXFTVGHROZHD-UHFFFAOYSA-N 0.000 description 1
- 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000006179 2-methyl benzyl group Chemical group [H]C1=C([H])C(=C(C([H])=C1[H])C([H])([H])*)C([H])([H])[H] 0.000 description 1
- DPXABRZASYWNOE-UHFFFAOYSA-N 2-methylbutane-1-sulfonic acid Chemical compound CCC(C)CS(O)(=O)=O DPXABRZASYWNOE-UHFFFAOYSA-N 0.000 description 1
- DBMBAVFODTXIDN-UHFFFAOYSA-N 2-methylbutane-2-sulfonic acid Chemical compound CCC(C)(C)S(O)(=O)=O DBMBAVFODTXIDN-UHFFFAOYSA-N 0.000 description 1
- XCJGLBWDZKLQCY-UHFFFAOYSA-N 2-methylpropane-2-sulfonic acid Chemical compound CC(C)(C)S(O)(=O)=O XCJGLBWDZKLQCY-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000006512 3,4-dichlorobenzyl group Chemical group [H]C1=C(Cl)C(Cl)=C([H])C(=C1[H])C([H])([H])* 0.000 description 1
- 125000006284 3-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(F)=C1[H])C([H])([H])* 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 125000006180 3-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000006032 3-methyl-3-butenyl group Chemical group 0.000 description 1
- HYZYOKHLDUXUQK-UHFFFAOYSA-N 3-methylbutane-1-sulfonic acid Chemical compound CC(C)CCS(O)(=O)=O HYZYOKHLDUXUQK-UHFFFAOYSA-N 0.000 description 1
- UPQGXHSGBPIDLB-UHFFFAOYSA-N 3-methylpentane-1-sulfonic acid Chemical compound CCC(C)CCS(O)(=O)=O UPQGXHSGBPIDLB-UHFFFAOYSA-N 0.000 description 1
- RKIDBHUPHXDVSM-UHFFFAOYSA-N 4-(2,2-dimethylpropyl)benzenesulfonic acid Chemical compound CC(C)(C)CC1=CC=C(S(O)(=O)=O)C=C1 RKIDBHUPHXDVSM-UHFFFAOYSA-N 0.000 description 1
- JSAWRAZHLDUMBF-UHFFFAOYSA-N 4-(2-methylbutan-2-yl)benzenesulfonic acid Chemical compound CCC(C)(C)C1=CC=C(S(O)(=O)=O)C=C1 JSAWRAZHLDUMBF-UHFFFAOYSA-N 0.000 description 1
- PSZREHLSDVDPLP-UHFFFAOYSA-N 4-(2-methylbutyl)benzenesulfonic acid Chemical compound CCC(C)CC1=CC=C(S(O)(=O)=O)C=C1 PSZREHLSDVDPLP-UHFFFAOYSA-N 0.000 description 1
- NMALHVJUMCYDAA-UHFFFAOYSA-N 4-(3-methylbutyl)benzenesulfonic acid Chemical compound CC(C)CCC1=CC=C(S(O)(=O)=O)C=C1 NMALHVJUMCYDAA-UHFFFAOYSA-N 0.000 description 1
- IVMBTSJHHLHMKS-UHFFFAOYSA-N 4-(3-methylpentyl)benzenesulfonic acid Chemical compound CCC(C)CCC1=CC=C(S(O)(=O)=O)C=C1 IVMBTSJHHLHMKS-UHFFFAOYSA-N 0.000 description 1
- RHFBUMIQLRXTKL-UHFFFAOYSA-N 4-(4-methylpentyl)benzenesulfonic acid Chemical compound C(CCC(C)C)C1=CC=C(C=C1)S(=O)(=O)O RHFBUMIQLRXTKL-UHFFFAOYSA-N 0.000 description 1
- CVLHGLWXLDOELD-UHFFFAOYSA-N 4-(Propan-2-yl)benzenesulfonic acid Chemical compound CC(C)C1=CC=C(S(O)(=O)=O)C=C1 CVLHGLWXLDOELD-UHFFFAOYSA-N 0.000 description 1
- CJEPULVXGOPGGJ-KTKRTIGZSA-N 4-[(z)-octadec-9-enyl]benzenesulfonic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCC1=CC=C(S(O)(=O)=O)C=C1 CJEPULVXGOPGGJ-KTKRTIGZSA-N 0.000 description 1
- OVXNLJHNNUAEMR-UHFFFAOYSA-N 4-butan-2-ylbenzenesulfonate;hydron Chemical compound CCC(C)C1=CC=C(S(O)(=O)=O)C=C1 OVXNLJHNNUAEMR-UHFFFAOYSA-N 0.000 description 1
- JNVFIMNBBVDEPV-UHFFFAOYSA-N 4-butylbenzenesulfonic acid Chemical compound CCCCC1=CC=C(S(O)(=O)=O)C=C1 JNVFIMNBBVDEPV-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- BRIXOPDYGQCZFO-UHFFFAOYSA-N 4-ethylphenylsulfonic acid Chemical compound CCC1=CC=C(S(O)(=O)=O)C=C1 BRIXOPDYGQCZFO-UHFFFAOYSA-N 0.000 description 1
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 1
- KJORMGGHDPSQSX-UHFFFAOYSA-N 4-hexadecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCCCCCC1=CC=C(S(O)(=O)=O)C=C1 KJORMGGHDPSQSX-UHFFFAOYSA-N 0.000 description 1
- DTOUBHFVJMFDNK-UHFFFAOYSA-N 4-hexan-3-ylbenzenesulfonic acid Chemical compound CCCC(CC)C1=CC=C(S(O)(=O)=O)C=C1 DTOUBHFVJMFDNK-UHFFFAOYSA-N 0.000 description 1
- AUHUWFIYJDRPJX-UHFFFAOYSA-N 4-hexylbenzenesulfonic acid Chemical compound CCCCCCC1=CC=C(S(O)(=O)=O)C=C1 AUHUWFIYJDRPJX-UHFFFAOYSA-N 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
- UJZKCQGCOVJQEM-UHFFFAOYSA-N 4-methylpentane-1-sulfonic acid Chemical compound CC(C)CCCS(O)(=O)=O UJZKCQGCOVJQEM-UHFFFAOYSA-N 0.000 description 1
- CXIXFMIBMZZTSA-UHFFFAOYSA-N 4-pentylbenzenesulfonic acid Chemical compound CCCCCC1=CC=C(S(O)(=O)=O)C=C1 CXIXFMIBMZZTSA-UHFFFAOYSA-N 0.000 description 1
- DUPJEKYVVIGXEJ-UHFFFAOYSA-N 4-propylbenzenesulfonic acid Chemical compound CCCC1=CC=C(S(O)(=O)=O)C=C1 DUPJEKYVVIGXEJ-UHFFFAOYSA-N 0.000 description 1
- LZQMCUIWYRQLOG-UHFFFAOYSA-N 4-tert-butylbenzenesulfonic acid Chemical compound CC(C)(C)C1=CC=C(S(O)(=O)=O)C=C1 LZQMCUIWYRQLOG-UHFFFAOYSA-N 0.000 description 1
- 125000001318 4-trifluoromethylbenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(F)(F)F 0.000 description 1
- 229950010481 5-aminolevulinic acid hydrochloride Drugs 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- RZXLPPRPEOUENN-UHFFFAOYSA-N Chlorfenson Chemical compound C1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=C(Cl)C=C1 RZXLPPRPEOUENN-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000220259 Raphanus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 159000000021 acetate salts Chemical class 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- QDHFHIQKOVNCNC-UHFFFAOYSA-N butane-1-sulfonic acid Chemical compound CCCCS(O)(=O)=O QDHFHIQKOVNCNC-UHFFFAOYSA-N 0.000 description 1
- BRXCDHOLJPJLLT-UHFFFAOYSA-N butane-2-sulfonic acid Chemical compound CCC(C)S(O)(=O)=O BRXCDHOLJPJLLT-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- SSILHZFTFWOUJR-UHFFFAOYSA-N hexadecane-1-sulfonic acid Chemical compound CCCCCCCCCCCCCCCCS(O)(=O)=O SSILHZFTFWOUJR-UHFFFAOYSA-N 0.000 description 1
- FYAQQULBLMNGAH-UHFFFAOYSA-N hexane-1-sulfonic acid Chemical compound CCCCCCS(O)(=O)=O FYAQQULBLMNGAH-UHFFFAOYSA-N 0.000 description 1
- OOZYQDUFRNYGBN-UHFFFAOYSA-N hexane-3-sulfonic acid Chemical compound CCCC(CC)S(O)(=O)=O OOZYQDUFRNYGBN-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- XHQZMUKGKLVRBX-UHFFFAOYSA-N hexyl 5-amino-4-oxopentanoate 4-methylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.CCCCCCOC(=O)CCC(=O)CN XHQZMUKGKLVRBX-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- JOOXCMJARBKPKM-UHFFFAOYSA-N laevulinic acid Natural products CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 1
- 229940040102 levulinic acid Drugs 0.000 description 1
- 125000005644 linolenyl group Chemical group 0.000 description 1
- 125000005645 linoleyl group Chemical group 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- MZWYPEXTXIBFKJ-UHFFFAOYSA-N methyl 5-amino-4-oxopentanoate 4-methylbenzenesulfonic acid Chemical compound COC(=O)CCC(=O)CN.CC1=CC=C(S(O)(=O)=O)C=C1 MZWYPEXTXIBFKJ-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- 125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NIXKBAZVOQAHGC-UHFFFAOYSA-N phenylmethanesulfonic acid Chemical compound OS(=O)(=O)CC1=CC=CC=C1 NIXKBAZVOQAHGC-UHFFFAOYSA-N 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- HNDXKIMMSFCCFW-UHFFFAOYSA-N propane-2-sulphonic acid Chemical compound CC(C)S(O)(=O)=O HNDXKIMMSFCCFW-UHFFFAOYSA-N 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Description
本発明は、微生物・発酵、動物・医療、植物等の分野において有用な5−アミノレブリン酸エステルスルホン酸類塩、その製造方法、これを含有する医療用組成物及びこれを含有する植物活力剤組成物に関する。 The present invention relates to a 5-aminolevulinic acid ester sulfonic acid salt useful in the fields of microorganisms / fermentation, animals / medicine, plants, and the like, a production method thereof, a medical composition containing the same, and a plant vital agent composition containing the same About.
5−アミノレブリン酸エステルの塩酸塩は、医療分野においては、がん治療(非特許文献1)、植物分野においては除草剤(特許文献1)、耐塩性向上剤(特許文献2)、種子処理剤(特許文献3)などに有用なことが知られている。 The hydrochloride of 5-aminolevulinic acid ester is a cancer treatment (Non-patent Document 1) in the medical field, a herbicide (Patent Document 1), a salt tolerance improver (Patent Document 2), and a seed treatment agent in the plant field. (Patent Document 3) is known to be useful.
一方、5−アミノレブリン酸エステル類は塩酸塩としてのみ製造法が知られており、例えば、5−アミノレブリン酸塩酸塩とアルコールを縮合剤存在下で縮合する方法(特許文献1)、5−アルコキシカルボキサミドレブリン酸エステルのアミノ基の保護基を除去する方法(特許文献1、非特許文献2)が報告されている。 On the other hand, the production method of 5-aminolevulinic acid esters is known only as a hydrochloride, for example, a method of condensing 5-aminolevulinic acid hydrochloride and alcohol in the presence of a condensing agent (Patent Document 1), 5-alkoxycarboxamide. A method for removing an amino-protecting group of levulinic acid ester (Patent Document 1, Non-Patent Document 2) has been reported.
一方、5−アミノレブリン酸エステル塩酸塩を動植物体或いはその細胞に投与する際には、滅菌操作が事前に必要な場合があり、その方法としては例えば特表2001−514243に記載されている放射線照射による滅菌方法が知られていた。
しかし、放射線照射による方法は特殊な装置が必要である。簡便な滅菌方法としては加熱滅菌法が挙げられるが、5−アミノレブリン酸エステル塩酸塩は融点が低い(耐熱性が低い)という性質があるため、加熱による滅菌方法では固体の相変化が伴ってしまい、過熱滅菌法の適用が困難であった。
However, the method by radiation irradiation requires a special device. As a simple sterilization method, there is a heat sterilization method, but 5-aminolevulinic acid ester hydrochloride has a property of low melting point (low heat resistance). Therefore, the sterilization method by heating involves a solid phase change. The application of the superheat sterilization method was difficult.
従って、本発明は、耐熱性に優れた5−アミノレブリン酸エステル類の新規な塩、その製造方法、これを含有する医療用組成物及び植物活力剤組成物を提供することにある。 Therefore, this invention is providing the novel salt of 5-aminolevulinic acid ester excellent in heat resistance, its manufacturing method, the medical composition containing this, and a plant vital agent composition.
本発明者らは、かかる実情に鑑み鋭意検討を行った結果、5−アミノレブリン酸スルホン酸類塩とアルコールを作用させることにより、上記要求が満たされる特定の5−アミノレブリン酸エステルスルホン酸類塩が得られることを見出し、本発明を完成させた。 As a result of intensive studies in view of such circumstances, the inventors of the present invention can obtain a specific 5-aminolevulinic acid ester sulfonic acid salt satisfying the above requirements by acting a 5-aminolevulinic acid sulfonic acid salt and an alcohol. As a result, the present invention has been completed.
すなわち、本発明は、下記一般式(1)
R1OCOCH2CH2COCH2NH2・HOSO2R2 (1)
〔式中、R1は、ヒドロキシ、アルコキシ、アシルオキシ、アルコキシカルボニルオキシ、アミノ、アリール、オキソ、フロロ、クロロ及びニトロから選ばれる基が置換していてもよい炭化水素基を示し;R2は、ヒドロキシ又はR1を示す。但し、R1とR2は同一でも、異なっていてもよい〕
で表される5−アミノレブリン酸エステルスルホン酸類塩を提供するものである。
That is, the present invention provides the following general formula (1)
R 1 OCOCH 2 CH 2 COCH 2 NH 2 · HOSO 2 R 2 (1)
Wherein, R 1 is hydroxy, alkoxy, acyloxy, alkoxycarbonyloxy, shows amino, aryl, oxo, fluoro, chloro and hydrocarbon radicals groups selected from nitro which may be substituted; R 2 is Hydroxy or R 1 is indicated. R 1 and R 2 may be the same or different.
The 5-aminolevulinic acid ester sulfonic acid salt represented by these is provided.
また、本発明は、下記一般式(2)
HOCOCH2CH2COCH2NH2・ HOSO2R2 (2)
〔R2は前記定義の通り〕
で表される5−アミノレブリン酸スルホン酸塩と下記一般式(3)
R1OH (3)
[R1は前記定義の通り]
で示されるアルコールを縮合させることを特徴とする、上記一般式(1)で表される5−アミノレブリン酸エステルスルホン酸類塩の製造方法を提供するものである。
Further, the present invention provides the following general formula (2)
HOCOCH 2 CH 2 COCH 2 NH 2 and HOSO 2 R 2 (2)
[R 2 is as defined above]
5-aminolevulinic acid sulfonate represented by the following general formula (3)
R 1 OH (3)
[R 1 is as defined above]
A method for producing a 5-aminolevulinic acid ester sulfonic acid salt represented by the above general formula (1), which comprises condensing an alcohol represented by formula (1).
更に本発明は、前記一般式(1)で表される5−アミノレブリン酸エステルスルホン酸類塩を含有する光力学的治療又は診断用組成物を提供するものである。本発明は、また更に、前記一般式(1)で表される5−アミノレブリン酸エステルスルホン酸類塩を含有する植物活力剤組成物を提供するものである。 Furthermore, the present invention provides a photodynamic therapeutic or diagnostic composition containing the 5-aminolevulinic acid ester sulfonic acid salt represented by the general formula (1). The present invention further provides a plant vitality composition containing a 5-aminolevulinic acid ester sulfonic acid salt represented by the general formula (1).
本発明の5−アミノレブリン酸エステルスルホン酸類塩は、分解温度が塩酸塩よりも高く、そのため加熱滅菌操作が簡便である。また、本発明の製造方法によれば、簡便且つ効率よく5−アミノレブリン酸エステルスルホン酸類塩を製造することができる。 The 5-aminolevulinic acid ester sulfonic acid salts of the present invention have a decomposition temperature higher than that of the hydrochloride, so that the heat sterilization operation is simple. Moreover, according to the manufacturing method of this invention, 5-aminolevulinic acid ester sulfonic acid salts can be manufactured simply and efficiently.
一般式(1)中、R1はヒドロキシ、アルコキシ、アシルオキシ、アルコキシカルボニルオキシ、アミノ、アリール、オキソ、フロロ、クロロ及びニトロから選ばれる基が置換していてもよい炭化水素基を示す。ここで、炭化水素基としては、アルキル基、アルケニル基、アラルキル基又はアリール基が好ましい。ここで、アルキル基としては、直鎖、分岐鎖又は環状のアルキル基が挙げられ、炭素数1〜40、更に1〜18、特に1〜7のアルキル基が好ましい。アルケニル基としては、直鎖、分岐鎖又は環状のアルケニル基が挙げられ、炭素数2〜40、更に2〜18のアルケニル基が好ましい。アラルキル基としては炭素数6〜20のアリール基と炭素数1〜6のアルキル基から構成されるものが挙げられる。また、アリール基としては炭素数6〜20のアリール基が挙げられる。 In the general formula (1), R 1 represents a hydrocarbon group which may be substituted with a group selected from hydroxy, alkoxy, acyloxy, alkoxycarbonyloxy, amino, aryl, oxo, fluoro, chloro and nitro. Here, the hydrocarbon group is preferably an alkyl group, an alkenyl group, an aralkyl group or an aryl group. Here, as an alkyl group, a linear, branched or cyclic alkyl group is mentioned, A C1-C40, Furthermore, a 1-18, especially 1-7 alkyl group is preferable. Examples of the alkenyl group include linear, branched or cyclic alkenyl groups, and alkenyl groups having 2 to 40 carbon atoms and more preferably 2 to 18 carbon atoms are preferable. Examples of the aralkyl group include those composed of an aryl group having 6 to 20 carbon atoms and an alkyl group having 1 to 6 carbon atoms. Moreover, as an aryl group, a C6-C20 aryl group is mentioned.
アルコキシ基としては炭素数1〜18のアルコキシ基、特に炭素数1〜7のアルコキシ基が好ましい。アシルオキシ基としては、炭素数1〜18のアルカノイルオキシ基、特に炭素数2〜8のアルカノイルオキシ基が好ましい。アルコキシカルボニルオキシ基としては、C1-18アルコキシ−カルボニルオキシ基、特にC1-7アルコキシ−カルボニルオキシ基が好ましい。 As an alkoxy group, a C1-C18 alkoxy group, especially a C1-C7 alkoxy group are preferable. The acyloxy group is preferably an alkanoyloxy group having 1 to 18 carbon atoms, particularly an alkanoyloxy group having 2 to 8 carbon atoms. As the alkoxycarbonyloxy group, a C 1-18 alkoxy-carbonyloxy group, particularly a C 1-7 alkoxy-carbonyloxy group is preferable.
炭素数1〜18の好ましいアルキル基としては例えば、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、tert−ブチル基、n−ペンチル基、イソペンチル基、ネオペンチル基、tert−ペンチル基、2−メチルブチル基、n−ヘキシル基、イソヘキシル基、3−メチルペンチル基、エチルブチル基、n−ヘプチル基、2−メチルヘキシル基、n−オクチル基、イソオクチル基、tert−オクチル基、2−エチルヘキシル基、3−メチルヘプチル基、n−ノニル基、イソノニル基、1−メチルオクチル基、エチルヘプチル基、n−デシル基、1−メチルノニル基、n−ウンデシル基、1,1−ジメチルノニル基、n−ドデシル基、n−トリデシル基、n−テトラデシル基、n−ペンタデシル基、n−ヘキサデシル基、n−ヘプタデシル基、n−オクタデシル基等が挙げられる。 Preferred examples of the alkyl group having 1 to 18 carbon atoms include methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, tert-butyl group, n-pentyl group, isopentyl group, and neopentyl group. Tert-pentyl group, 2-methylbutyl group, n-hexyl group, isohexyl group, 3-methylpentyl group, ethylbutyl group, n-heptyl group, 2-methylhexyl group, n-octyl group, isooctyl group, tert-octyl group Group, 2-ethylhexyl group, 3-methylheptyl group, n-nonyl group, isononyl group, 1-methyloctyl group, ethylheptyl group, n-decyl group, 1-methylnonyl group, n-undecyl group, 1,1- Dimethylnonyl group, n-dodecyl group, n-tridecyl group, n-tetradecyl group, n-pentadecyl group, - hexadecyl group, n- heptadecyl group, n- octadecyl group.
炭素数1〜7のより好ましいアルキル基としては例えば、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、tert−ブチル基、n−ペンチル基、イソペンチル基、ネオペンチル基、tert−ペンチル基、2−メチルブチル基、n−ヘキシル基、イソヘキシル基、3−メチルペンチル基、エチルブチル基、n−ヘプチル基、2−メチルヘキシル基が挙げられる。 More preferable examples of the alkyl group having 1 to 7 carbon atoms include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, and neopentyl. Group, tert-pentyl group, 2-methylbutyl group, n-hexyl group, isohexyl group, 3-methylpentyl group, ethylbutyl group, n-heptyl group and 2-methylhexyl group.
フロロが置換している場合のフロロの数は、1〜37個の範囲であればよく、置換する位置に制限はないが、好ましくは-(CH2)M(CF2)NR3〔Mは0〜6、Nは1〜7の整数を示す。ただし、MとNの和は1〜7である。R3が水素又はフロロを示す。〕で示される基であり、例えば、2,2,2−トリフロロエチル、3,3,3−トリフロロプロピル、2,2,3,3,3−ペンタフロロプロピル、4,4,4−トリフロロブチル、3,3,4,4,4−ペンタフロロブチル、2,2,3,3,4,4,4−へプタフロロブチル、5,5,5−トリフロロペンチル、4,4,5,5,5−ペンタフロロペンチル、2,2,3,3,4,4,5,5−オクタフロロペンチル、3,3,4,4,5,5,−ヘキサフロロペンチル、3,3,4,4,5,5,5−へプタフロロペンチル、2,2,3,3,4,4,5,5,5−ノナフロロペンチル、6,6,6−トリフロロヘキシル、5,5,6,6,6−ペンタフロロヘキシル、4,4,5,5,6,6,6−へプタフロロヘキシル、3,3,4,4,5,5,6,6,6−ノナフロロヘキシル、2,2,3,3,4,4,5,5,6,6,6−ウンデカフロロヘキシル、7,7,7−トリフロロヘプチル、6,6,7,7,7−ペンタフロロヘプチル、5,5,6,6,7,7,7−ヘプタフロロヘプチル、4,4,5,5,6,6,7,7,7−ノナフロロヘプチル、3,3,4,4,5,5,6,6,7,7,7−ウンデカフロロヘプチル、2,2,3,3,4,4,5,5,6,6,7,7,7−トリデカフロロヘプチル等が挙げられ、特に好ましくは、2,2,3,3,4,4,4−ヘプタフロロブチル、2,2,3,3,4,4,5,5−オクタフロロペンチル、3,3,4,4,5,5,6,6,6−ノナフロロヘキシル、2,2,3,3,4,4,5,5,6,6,7,7,7−トリデカフロロヘプチルである。 When the fluoro is substituted, the number of fluoro may be in the range of 1 to 37, and the position to be substituted is not limited, but preferably-(CH 2 ) M (CF 2 ) N R 3 [M 0 to 6 and N represents an integer of 1 to 7. However, the sum of M and N is 1-7. R 3 represents hydrogen or fluoro. ], For example, 2,2,2-trifluoroethyl, 3,3,3-trifluoropropyl, 2,2,3,3,3-pentafluoropropyl, 4,4,4- Trifluorobutyl, 3,3,4,4,4-pentafluorobutyl, 2,2,3,3,4,4,4-heptafluorobutyl, 5,5,5-trifluoropentyl, 4,4,5 , 5,5-pentafluoropentyl, 2,2,3,3,4,4,5,5-octafluoropentyl, 3,3,4,4,5,5,5-hexafluoropentyl, 3,3 4,4,5,5,5-heptafluoropentyl, 2,2,3,3,4,4,5,5,5-nonafluoropentyl, 6,6,6-trifluorohexyl, 5,5 , 6,6,6-pentafluorohexyl, 4,4,5,5,6,6,6-heptafluorohexyl, 3,3, , 4,5,5,6,6,6-nonafluorohexyl, 2,2,3,3,4,4,5,5,6,6,6-undecafluorohexyl, 7,7,7- Trifluoroheptyl, 6,6,7,7,7-pentafluoroheptyl, 5,5,6,6,7,7,7-heptafluoroheptyl, 4,4,5,5,6,6,7, 7,7-nonafluoroheptyl, 3,3,4,4,5,5,6,6,7,7,7-undecafluoroheptyl, 2,2,3,3,4,4,5,5 , 6,6,7,7,7-tridecafluoroheptyl and the like, particularly preferably 2,2,3,3,4,4,4-heptafluorobutyl, 2,2,3,3, and the like. 4,4,5,5-octafluoropentyl, 3,3,4,4,5,5,6,6,6-nonafluorohexyl, 2,2,3,3,4,4,5,5 6, 6, Is a 7,7-bird decafluoro heptyl.
ヒドロキシが置換した炭素数1〜18のアルキル基としては、2−ヒドロキシエチル、3−ヒドロキシプロピル、4−ヒドロキシブチル、5−ヒドロキシペンチル、6−ヒドロキシヘキシル等が挙げられる。 Examples of the alkyl group having 1 to 18 carbon atoms substituted by hydroxy include 2-hydroxyethyl, 3-hydroxypropyl, 4-hydroxybutyl, 5-hydroxypentyl, 6-hydroxyhexyl and the like.
アルコキシが置換した炭素数1〜18のアルキル基としては、C1-7アルコキシ−C1-18アルキル基、例えば2−メトキシエチル、2−エトキシエチル、3−メトキシプロピル、3−エトキシプロピル、4−メトキシブチル、4−エトキシブチル、2−(2−メトキシエチル)エチル等が挙げられる。 Examples of the C1- C18 alkyl group substituted by alkoxy include C 1-7 alkoxy-C 1-18 alkyl groups such as 2-methoxyethyl, 2-ethoxyethyl, 3-methoxypropyl, 3-ethoxypropyl, 4 -Methoxybutyl, 4-ethoxybutyl, 2- (2-methoxyethyl) ethyl and the like.
アシルオキシ基が置換したアルキル基としては、C2-7アルカノイルオキシ−C1-18アルキル基が挙げられる。アルコキシカルボニルオキシ基が置換したアルキル基としては、C1-18アルコキシ−カルボニルオキシ−C1-18アルキル基が挙げられる。アミノ基が置換したアルキル基としては、アミノ−C1-18アルキル基が挙げられる。
炭素数2〜18のアルケニル基としては、ビニル基、アリル基、イソプロペニル基、2−ブテニル基、2−メチルアリル基、1,1−ジメチルアリル基、3−メチル−2−ブテニル基、3−メチル−3−ブテニル基、4−ペンテニル基、ヘキセニル基、オクテニル基、ノネニル基、デセニル基、シクロプロペニル基、シクロブテニル基、シクロペンテニル基、シクロヘキセニル基、シクロヘプテニル基、シクロオクテニル基、4−メチルシクロヘキセニル基、4−エチルシクロヘキセニル基、2−シクロペンテニルエチル基、シクロヘキセニルメチル基、シクロヘプテニルメチル基、2−シクロブテニルエチル基、2−シクロオクテニルエチル基、3−(4−メチルシクロヘキセニル)プロピル基、4−シクロプロペニルブチル基、5−(4−エチルシクロヘキセニル)ペンチル基、オレイル基、バクセニル基、リノレイル基、リノレニル基、trans−9−オクタデセニル基、9E,12E−オクタデカジエニル基、9E,12E,15E−オクタデカトリエニル基等が挙げられる。
Examples of the alkyl group substituted with an acyloxy group include a C 2-7 alkanoyloxy-C 1-18 alkyl group. Examples of the alkyl group substituted by an alkoxycarbonyloxy group include a C 1-18 alkoxy-carbonyloxy-C 1-18 alkyl group. Examples of the alkyl group substituted with an amino group include an amino-C 1-18 alkyl group.
Examples of the alkenyl group having 2 to 18 carbon atoms include vinyl group, allyl group, isopropenyl group, 2-butenyl group, 2-methylallyl group, 1,1-dimethylallyl group, 3-methyl-2-butenyl group, 3- Methyl-3-butenyl group, 4-pentenyl group, hexenyl group, octenyl group, nonenyl group, decenyl group, cyclopropenyl group, cyclobutenyl group, cyclopentenyl group, cyclohexenyl group, cycloheptenyl group, cyclooctenyl group, 4-methylcyclohexenyl Group, 4-ethylcyclohexenyl group, 2-cyclopentenylethyl group, cyclohexenylmethyl group, cycloheptenylmethyl group, 2-cyclobutenylethyl group, 2-cyclooctenylethyl group, 3- (4-methylcyclo Hexenyl) propyl group, 4-cyclopropenylbutyl group, 5- (4 Ethylcyclohexenyl) pentyl group, oleyl group, bacenyl group, linoleyl group, linolenyl group, trans-9-octadecenyl group, 9E, 12E-octadecadienyl group, 9E, 12E, 15E-octadecatrienyl group, etc. It is done.
炭素数7〜26のアラルキル基としては、炭素数1〜6のアルキル基と炭素数6〜20のアリール基とから構成されるものが好ましい。炭素数1〜6のアルキル基としては、例えば、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、tert−ブチル基、n−ペンチル基、n−ヘキシル基、シクロプロピル基、シクロブチル基、シクロヘキシル基等が挙げられ、炭素数6〜20のアリール基としては、フェニル基、ナフチル基等が挙げられる。炭素数7〜26のアラルキル基のうち、ベンジル基、フェネチル基、9−フルオレニルメチル基が好ましく、ベンジル基、フルオレニルメチル基が特に好ましい。当該アラルキル基のアリール基は、上記記載の炭素数1〜6のアルキル基、メトキシ基、エトキシ基、n−プロポキシ基、n−ブトキシ基、イソブトキシ基、tert−ブトキシ基等の炭素数1〜6のアルコキシ基、水酸基、アミノ基、ニトロ基、シアノ基、フッ素、塩素、臭素、ヨウ素等のハロゲン原子、カルボキシ基等の置換基1〜3個によって置換されていてもよい。このような置換されたアラルキル基としては、−CH2C6H4FpR4(R4は水素、フロロ、クロロ、メチル、エチル、プロピル、ブチル、トリフロロメチル、ニトロ及びメトキシから選ばれる基を示し、pは0〜4の整数を示す)で示される基が挙げられ、特に2−メチルベンジル、3−メチルベンジル、4−メチルベンジル、4−メトキシベンジル、4−トリフロロメチルベンジル、4−クロロベンジル、3,4−ジクロロベンジル、2−フロロベンジル、3−フロロベンジル、4−フロロベンジル、3−ニトロベンジル、4−ニトロベンジル、2,3,4,5−テトラフロロベンジル、2,3,4,5,6−ペンタフロロベンジルが好ましい。 The aralkyl group having 7 to 26 carbon atoms is preferably one composed of an alkyl group having 1 to 6 carbon atoms and an aryl group having 6 to 20 carbon atoms. Examples of the alkyl group having 1 to 6 carbon atoms include methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, tert-butyl group, n-pentyl group, n-hexyl group, A cyclopropyl group, a cyclobutyl group, a cyclohexyl group, etc. are mentioned, As a C6-C20 aryl group, a phenyl group, a naphthyl group, etc. are mentioned. Of the aralkyl groups having 7 to 26 carbon atoms, a benzyl group, a phenethyl group, and a 9-fluorenylmethyl group are preferable, and a benzyl group and a fluorenylmethyl group are particularly preferable. The aryl group of the aralkyl group has 1 to 6 carbon atoms such as the above-described alkyl group having 1 to 6 carbon atoms, methoxy group, ethoxy group, n-propoxy group, n-butoxy group, isobutoxy group, tert-butoxy group and the like. May be substituted by 1 to 3 substituents such as a carboxy group or a halogen atom such as an alkoxy group, a hydroxyl group, an amino group, a nitro group, a cyano group, fluorine, chlorine, bromine or iodine. As such a substituted aralkyl group, —CH 2 C 6 H 4 F p R 4 (R 4 is selected from hydrogen, fluoro, chloro, methyl, ethyl, propyl, butyl, trifluoromethyl, nitro and methoxy. And p represents an integer of 0 to 4), particularly 2-methylbenzyl, 3-methylbenzyl, 4-methylbenzyl, 4-methoxybenzyl, 4-trifluoromethylbenzyl, 4-chlorobenzyl, 3,4-dichlorobenzyl, 2-fluorobenzyl, 3-fluorobenzyl, 4-fluorobenzyl, 3-nitrobenzyl, 4-nitrobenzyl, 2,3,4,5-tetrafluorobenzyl, 2 , 3,4,5,6-pentafluorobenzyl is preferred.
炭素数6〜20のアリール基としては、フェニル基、ナフチル基等が挙げられ、例えば、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、tert−ブチル基、n−ペンチル基、n−ヘキシル基、シクロプロピル基、シクロブチル基、シクロヘキシル基等の炭素数1〜6のアルキル基、メトキシ基、エトキシ基、n−プロポキシ基、n−ブトキシ基、イソブトキシ基、tert−ブトキシ基等の炭素数1〜6のアルコキシ基、水酸基、アミノ基、ニトロ基、シアノ基、フッ素、塩素、臭素、ヨウ素等のハロゲン原子、カルボキシ基等の置換基1〜3個によって置換されていてもよい。 Examples of the aryl group having 6 to 20 carbon atoms include a phenyl group and a naphthyl group. For example, a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, an isobutyl group, a tert-butyl group, C1-C6 alkyl group such as n-pentyl group, n-hexyl group, cyclopropyl group, cyclobutyl group, cyclohexyl group, methoxy group, ethoxy group, n-propoxy group, n-butoxy group, isobutoxy group, tert -Substituted by 1 to 3 substituents such as a C1-C6 alkoxy group such as a butoxy group, a hydroxyl group, an amino group, a nitro group, a cyano group, a halogen atom such as fluorine, chlorine, bromine or iodine, or a carboxy group It may be.
一般式(1)中のR2は、ヒドロキシ又は前記R1で示される基である。R2としては、前記のR1で説明した基がすべて例示される。このうちR2としては、炭素数1〜18のアルキル基、アラルキル基又はアリール基が好ましい。炭素数1〜18のアルキル基としては例えば、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、tert−ブチル基、n−ペンチル基、イソペンチル基、ネオペンチル基、tert−ペンチル基、2−メチルブチル基、n−ヘキシル基、イソヘキシル基、3−メチルペンチル基、エチルブチル基、n−ヘプチル基、2−メチルヘキシル基、n−オクチル基、イソオクチル基、tert−オクチル基、2−エチルヘキシル基、3−メチルヘプチル基、n−ノニル基、イソノニル基、1−メチルオクチル基、エチルヘプチル基、n−デシル基、1−メチルノニル基、n−ウンデシル基、1,1−ジメチルノニル基、n−ドデシル基、n−トリデシル基、n−テトラデシル基、n−ペンタデシル基、n−ヘキサデシル基、n−ヘプタデシル基、n−オクタデシル基等が挙げられ、好ましくは炭素数1〜16のアルキル基であり、更に好ましくは、メチル基、エチル基、n−プロピル基、イソプロピル基、n−ブチル基、イソブチル基、tert−ブチル基、n−ペンチル基、イソペンチル基、ネオペンチル基、tert−ペンチル基、n−ヘキサデシル基、2−エチルヘキシル基が挙げられる。アラルキル基としてはベンジル基が好ましく、アリール基としてはフェニル基が好ましい。 R 2 in the general formula (1) is hydroxy or a group represented by R 1 . Examples of R 2 include all the groups described for R 1 above. Among these, as R < 2 >, a C1-C18 alkyl group, an aralkyl group, or an aryl group is preferable. Examples of the alkyl group having 1 to 18 carbon atoms include methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, tert-butyl group, n-pentyl group, isopentyl group, neopentyl group, tert-pentyl group, 2-methylbutyl group, n-hexyl group, isohexyl group, 3-methylpentyl group, ethylbutyl group, n-heptyl group, 2-methylhexyl group, n-octyl group, isooctyl group, tert-octyl group 2-ethylhexyl group, 3-methylheptyl group, n-nonyl group, isononyl group, 1-methyloctyl group, ethylheptyl group, n-decyl group, 1-methylnonyl group, n-undecyl group, 1,1-dimethyl Nonyl group, n-dodecyl group, n-tridecyl group, n-tetradecyl group, n-pentadecyl group, n-hex A decyl group, n-heptadecyl group, n-octadecyl group, etc. are mentioned, Preferably it is a C1-C16 alkyl group, More preferably, a methyl group, an ethyl group, n-propyl group, isopropyl group, n- Examples thereof include a butyl group, isobutyl group, tert-butyl group, n-pentyl group, isopentyl group, neopentyl group, tert-pentyl group, n-hexadecyl group, and 2-ethylhexyl group. The aralkyl group is preferably a benzyl group, and the aryl group is preferably a phenyl group.
一般式(1)で表わされる本発明の5−アミノレブリン酸エステルスルホン酸類塩は、固体でも液体でもよい。固体とは、結晶状態、ガラス状態又は液晶状態を示すが、それらが水和物であってもよい。液体とは固体が融解した状態或いは溶液を指す。溶液とは、水をはじめとする溶媒に溶解又は分散した状態を示すが、そのpHがpH調整剤等によって調整されたものでもよい。また、水をはじめとする溶媒は、2種以上を混合して使用してもよい。pH調整剤としては、リン酸、ホウ酸、フタル酸、クエン酸、コハク酸、トリス、酢酸、乳酸、酒石酸、シュウ酸、フタル酸、マレイン酸やそれらの塩などを用いた緩衝液又はグッドの緩衝液が挙げられる。 The 5-aminolevulinic acid ester sulfonic acid salt of the present invention represented by the general formula (1) may be solid or liquid. The solid indicates a crystalline state, a glass state, or a liquid crystal state, and may be a hydrate. The liquid refers to a melted state or solution. The solution means a state in which it is dissolved or dispersed in a solvent such as water, but the pH may be adjusted with a pH adjuster or the like. In addition, two or more kinds of solvents including water may be mixed and used. pH adjusters include phosphoric acid, boric acid, phthalic acid, citric acid, succinic acid, tris, acetic acid, lactic acid, tartaric acid, oxalic acid, phthalic acid, maleic acid and their salts. A buffer solution may be mentioned.
本発明の5−アミノレブリン酸エステルスルホン酸類塩(1)は、下記一般式(2)
HOCOCH2CH2COCH2NH2・ HOSO2R2 (2)
[式中、R2は前記定義の通り]
で表される化合物と下記一般式(3)
R1OH (3)
[式中、R1は、前記定義の通り]
で表される化合物を縮合させることにより製造される。反応は、化合物(2)を化合物(3)に溶解又は分散させ、加熱攪拌すれば得ることができる。
The 5-aminolevulinic acid ester sulfonic acid salt (1) of the present invention has the following general formula (2):
HOCOCH 2 CH 2 COCH 2 NH 2 and HOSO 2 R 2 (2)
[Wherein R 2 is as defined above]
And a compound represented by the following general formula (3)
R 1 OH (3)
[Wherein R 1 is as defined above]
It is manufactured by condensing the compound represented by these. The reaction can be obtained by dissolving or dispersing compound (2) in compound (3) and stirring with heating.
また、化合物(2)の代わりに5−アミノレブリン酸のその他の塩、例えば、塩酸塩、臭化水素酸塩、ヨウ化水素酸塩、硝酸塩、ホウ酸塩、フタル酸塩、クエン酸塩、コハク酸塩、酢酸塩、乳酸塩、酒石酸塩、シュウ酸塩、マレイン酸塩等を原料に用いることもできる。この場合、反応終了後に更にスルホン酸類を反応させればよい。 Further, instead of the compound (2), other salts of 5-aminolevulinic acid, such as hydrochloride, hydrobromide, hydroiodide, nitrate, borate, phthalate, citrate, succinate Acid salts, acetate salts, lactate salts, tartrate salts, oxalate salts, maleate salts and the like can also be used as raw materials. In this case, after completion of the reaction, sulfonic acids may be further reacted.
溶解状態や分散状態が思わしくない場合には適当な溶媒を加えて希釈することができる。
このような溶媒としては、水、ケトン類(アセトン、メチルエチルケトン等)、エステル類(酢酸メチル、酢酸エチル、酢酸プロピル、酢酸ブチル、γ−ブチロラクトン等)、エーテル類(ジエチルエーテル、メチルtert−ブチルエーテル、エチルtert−ブチルエーテル、ジメトキシエタン、テトラヒドロフラン、ジオキサン等)が挙げられる。加熱する場合の温度に特に制限はないが、好ましくは室温〜100℃である。
When the dissolved state or dispersed state is not desired, an appropriate solvent can be added for dilution.
Examples of the solvent include water, ketones (acetone, methyl ethyl ketone, etc.), esters (methyl acetate, ethyl acetate, propyl acetate, butyl acetate, γ-butyrolactone, etc.), ethers (diethyl ether, methyl tert-butyl ether, Ethyl tert-butyl ether, dimethoxyethane, tetrahydrofuran, dioxane and the like). Although there is no restriction | limiting in particular in the temperature in the case of heating, Preferably it is room temperature-100 degreeC.
また、反応は縮合剤を用いて行ってもよい。そのような縮合剤としては、ジシクロヘキシルカルボジイミド、ジイソプロピルカルボジイミド、N−エチル−N’−3−ジメチルアミノプロピルカルボジイミド及びその塩酸塩、ベンゾトリアゾール−1−イル−トリス(ジメチルアミノ)ホスホニウムヘキサフロロリン化物塩、ジフェニルホスホリルアジドなどが挙げられる。 The reaction may be performed using a condensing agent. Such condensing agents include dicyclohexylcarbodiimide, diisopropylcarbodiimide, N-ethyl-N′-3-dimethylaminopropylcarbodiimide and its hydrochloride, benzotriazol-1-yl-tris (dimethylamino) phosphonium hexafluorophosphate salt And diphenylphosphoryl azide.
また更に一般式(5)
HOSO2R2 (5)
(式中、R2は前記定義の通り)
で表されるスルホン酸類の存在下で縮合させることもできる。そのようなスルホン酸類としては、例えば、メチルスルホン酸、エチルスルホン酸、n−プロピルスルホン酸、イソプロピルスルホン酸、n−ブチルスルホン酸、sec−ブチルスルホン酸、tert−ブチルスルホン酸、n−ペンチルスルホン酸、イソペンチルスルホン酸、ネオペンチルスルホン酸、tert−ペンチルスルホン酸、2−メチルブチルスルホン酸、n−ヘキシルスルホン酸、イソヘキシルスルホン酸、3−メチルペンチルスルホン酸、エチルブチルスルホン酸、ヘキサデシルスルホン酸、2−エチルヘキシルスルホン酸、オレイルスルホン酸、ベンジルスルホン酸、ベンゼンスルホン酸、4−メチルベンゼンスルホン酸、2,4−ジメチルベンゼンスルホン酸、2,5−ジメチルベンゼンスルホン酸、4−エチルベンゼンスルホン酸、4−(n−プロピル)ベンゼンスルホン酸、4−イソプロピルベンゼンスルホン酸、4−(n−ブチル)ベンゼンスルホン酸、4−(sec−ブチル)ベンゼンスルホン酸、4−(tert−ブチル)ベンゼンスルホン酸、4−(n−ペンチル)ベンゼンスルホン酸、4−(イソペンチル)ベンゼンスルホン酸、4−(ネオペンチル)ベンゼンスルホン酸、4−(tert−ペンチル)ベンゼンスルホン酸、4−(2−メチルブチル)ベンゼンスルホン酸、4−(n−ヘキシル)ベンゼンスルホン酸、4−イソヘキシルベンゼンスルホン酸、4−(3−メチルペンチル)ベンゼンスルホン酸、4−(エチルブチル)ベンゼンスルホン酸、4−(ヘキサデシル)ベンゼンスルホン酸、4−(2−エチルヘキシル)ベンゼンスルホン酸、4−オレイルベンゼンスルホン酸等が挙げられる。
Furthermore, the general formula (5)
HOSO 2 R 2 (5)
(Wherein R 2 is as defined above)
It is also possible to condense in the presence of sulfonic acids represented by Examples of such sulfonic acids include methyl sulfonic acid, ethyl sulfonic acid, n-propyl sulfonic acid, isopropyl sulfonic acid, n-butyl sulfonic acid, sec-butyl sulfonic acid, tert-butyl sulfonic acid, n-pentyl sulfone. Acid, isopentylsulfonic acid, neopentylsulfonic acid, tert-pentylsulfonic acid, 2-methylbutylsulfonic acid, n-hexylsulfonic acid, isohexylsulfonic acid, 3-methylpentylsulfonic acid, ethylbutylsulfonic acid, hexadecyl Sulfonic acid, 2-ethylhexylsulfonic acid, oleylsulfonic acid, benzylsulfonic acid, benzenesulfonic acid, 4-methylbenzenesulfonic acid, 2,4-dimethylbenzenesulfonic acid, 2,5-dimethylbenzenesulfonic acid, 4-ethylbenzene Sulfonic acid, 4- (n-propyl) benzenesulfonic acid, 4-isopropylbenzenesulfonic acid, 4- (n-butyl) benzenesulfonic acid, 4- (sec-butyl) benzenesulfonic acid, 4- (tert-butyl) Benzenesulfonic acid, 4- (n-pentyl) benzenesulfonic acid, 4- (isopentyl) benzenesulfonic acid, 4- (neopentyl) benzenesulfonic acid, 4- (tert-pentyl) benzenesulfonic acid, 4- (2-methylbutyl ) Benzenesulfonic acid, 4- (n-hexyl) benzenesulfonic acid, 4-isohexylbenzenesulfonic acid, 4- (3-methylpentyl) benzenesulfonic acid, 4- (ethylbutyl) benzenesulfonic acid, 4- (hexadecyl) Benzenesulfonic acid, 4- (2-ethylhexyl) benzenesulfone , And 4-oleyl benzenesulfonic acid.
反応液から固体を回収する場合は、反応液に貧溶媒を加えることで可能である。貧溶媒は反応溶媒よりも極性の低い溶媒であれば特に制限はないが、好ましくは上記の反応溶媒から選択したものである。固体の回収率が低い場合は冷却することによって回収率を向上させることができる。 When recovering the solid from the reaction solution, it is possible to add a poor solvent to the reaction solution. The poor solvent is not particularly limited as long as it is a solvent having a polarity lower than that of the reaction solvent, but is preferably selected from the above reaction solvents. When the solid recovery rate is low, the recovery rate can be improved by cooling.
5−アミノレブリン酸エステルスルホン酸類塩(1)は、後記実施例に示すように、5−アミノレブリン酸エステル塩酸塩に比べて、耐熱性が高く、また、分解しにくい。従って、加熱による滅菌が容易で5−アミノレブリン酸エステルスルホン酸類塩は、5−アミノレブリン酸エステル塩酸塩と同様に、ヒトを含む動物における光力学的治療又は光力学的診断剤として有用である。光力学的治療又は診断剤としては、癌、感染症、リウマチ、血栓、にきび等の治療又は診断剤が挙げられる。 As shown in the examples below, 5-aminolevulinic acid ester sulfonic acid salts (1) have higher heat resistance and are difficult to decompose. Therefore, sterilization by heating is easy, and 5-aminolevulinic acid ester sulfonic acid salts are useful as photodynamic therapy or photodynamic diagnostic agents in animals including humans, like 5-aminolevulinic acid ester hydrochloride. Examples of the photodynamic therapy or diagnostic agent include those for cancer, infection, rheumatism, thrombus, acne and the like.
5−アミノレブリン酸エステルスルホン酸類塩の光力学的治療剤又は診断剤としての使用に際しては、公知の条件で使用すればよく、具体的には、特表2001−501970号公報、特表平4−500770号公報、特表2005−501050号公報、特表2004−506005号公報、特表2001−518498号公報、特表平8−507755号公報、特表2004−505105号公報、特表平11−501914号公報に開示されている処方、方法で使用すれば良い。 When the 5-aminolevulinic acid ester sulfonic acid salt is used as a photodynamic therapeutic agent or diagnostic agent, it may be used under known conditions. Specifically, JP-T-2001-501970, JP-T 4- No. 500770, No. 2005-501050, No. 2004-506005, No. 2001-518498, No. 8-507755, No. 2004-505105, No. 11- What is necessary is just to use it by the prescription and method currently disclosed by 501914 gazette.
5−アミノレブリン酸エステルスルホン酸類塩を含有する光力学的治療又は光力学的診断用組成物は、皮膚外用剤、注射剤、経口剤、座剤等の剤形にすることができる。これらの剤形にするにあたっては、薬学的に許容される担体を用いることができる。当該担体としては、水、結合剤、崩壊剤、溶解促進剤、潤沢剤、充填剤、賦形剤等が用いられる。 The composition for photodynamic treatment or photodynamic diagnosis containing a 5-aminolevulinic acid ester sulfonic acid salt can be made into a dosage form such as an external preparation for skin, an injection, an oral preparation, or a suppository. In preparing these dosage forms, a pharmaceutically acceptable carrier can be used. As the carrier, water, a binder, a disintegrant, a dissolution accelerator, a lubricant, a filler, an excipient and the like are used.
また、5−アミノレブリン酸エステルスルホン酸類塩を例えば、植物用途に使用する場合、一般的に使用される肥料成分等を含有しても良い。肥料成分としては、特開平4−338305号公報に開示されている物質が挙げられる。
5−アミノレブリン酸エステルスルホン酸類塩は、植物活性化剤としても有用である。植物活性化剤としての使用に際しては、公知の条件で使用すればよく、具体的には、特開平7−53487号公報に開示されている方法で植物に対して使用すればよい。
Moreover, when using 5-aminolevulinic acid ester sulfonic acid salt for a plant use, you may contain the fertilizer component etc. which are generally used, for example. As a fertilizer component, the substance currently disclosed by Unexamined-Japanese-Patent No. 4-338305 is mentioned.
5-Aminolevulinic acid ester sulfonic acid salts are also useful as plant activators. When used as a plant activator, it may be used under known conditions. Specifically, it may be used for plants by the method disclosed in JP-A-7-53487.
次に、実施例を挙げて本発明を具体的に説明するが、本発明の範囲はこれらに限定されるものではない。 Next, the present invention will be specifically described with reference to examples, but the scope of the present invention is not limited thereto.
実施例1 5−アミノレブリン酸メチルエステルp−トルエンスルホン酸塩の製造
5−アミノレブリン酸p−トルエンスルホン酸塩504.7 mg(1.64 mmol)とp−トルエンスルホン酸一水和物1.9 mg(0.01 mmol)をメタノール3 mLに加え、60 ℃で16時間攪拌した。反応液を冷却した後、イソプロパノール40 mLを加えて30分間攪拌した。析出した結晶をろ過回収し、室温下で減圧乾燥した後、目的物286.5 mg(0.903 mmol)を得た。回収率55 mol%。
1H-NMR(D2O, 400 MHz)δ ppm:2.38(s, 3H, Aromatic-CH3), 2.68(t, 2H, CH2), 2.87(t, 2H, CH2), 3.67(s, 3H, OCH3), 4.10(s, 2H, CH2), 7.35(d, 2H, Ar-H), 7.68(d, 2H, Ar-H)
13C-NMR(D2O, 100 MHz)δ ppm: 23(CH3), 30(CH2), 37(CH2), 50(CH2), 55(OCH3), 128(Aromatic), 132(Aromatic), 142(Aromatic), 145(Aromatic), 178(COO), 207(C=O)
元素分析値:C6H11NO3・C7H8SO3として
理論値:C 49.20%; H 6.03%; N 4.41%
実測値:C 49.0%; H 5.9%; N 4.3%
Example 1 Preparation of 5-aminolevulinic acid methyl ester p-toluenesulfonate 50-4.7 mg (1.64 mmol) of 5-aminolevulinic acid p-toluenesulfonate and 1.9 mg (0.01 mmol) of p-toluenesulfonic acid monohydrate The mixture was added to 3 mL of methanol and stirred at 60 ° C. for 16 hours. After cooling the reaction solution, 40 mL of isopropanol was added and stirred for 30 minutes. The precipitated crystals were collected by filtration and dried under reduced pressure at room temperature to obtain 286.5 mg (0.903 mmol) of the desired product. Recovery 55 mol%.
1 H-NMR (D 2 O, 400 MHz) δ ppm: 2.38 (s, 3H, Aromatic-CH 3 ), 2.68 (t, 2H, CH 2 ), 2.87 (t, 2H, CH 2 ), 3.67 (s , 3H, OCH 3 ), 4.10 (s, 2H, CH 2 ), 7.35 (d, 2H, Ar-H), 7.68 (d, 2H, Ar-H)
13 C-NMR (D 2 O, 100 MHz) δ ppm: 23 (CH 3 ), 30 (CH 2 ), 37 (CH 2 ), 50 (CH 2 ), 55 (OCH 3 ), 128 (Aromatic), 132 (Aromatic), 142 (Aromatic), 145 (Aromatic), 178 (COO), 207 (C = O)
Elemental analysis values: C 6 H 11 NO 3 and C 7 H 8 SO 3 Theoretical values: C 49.20%; H 6.03%; N 4.41%
Actual value: C 49.0%; H 5.9%; N 4.3%
実施例2 5−アミノレブリン酸ヘキシルエステルp−トルエンスルホン酸塩の製造
5−アミノレブリン酸p−トルエンスルホン酸塩506.6 mg(1.64 mmol)とp−トルエンスルホン酸一水和物1.9 mg(0.01 mmol)をn−ヘキサノール3 mLに加え、80 ℃で16時間攪拌した。反応液を冷却した後、シクロヘキサン20 mLを加えて攪拌し、4℃で18時間静置した。析出した結晶をろ過回収し、室温下で減圧乾燥した後、目的物520.4 mg(1.34 mmol)を得た。回収率82 mol%。
1H-NMR(D2O, 400 MHz)δ ppm:0.85(t, 3H, CH3), 1.28(s, 6H, 3CH2), 1.59(t, 2H, CH2), 2.37(s, 3H, Aromatic-CH3), 2.65(t, 2H, CH2), 2.86(t, 2H, CH2), 4.07(t, 4H, 2CH2), 7.34(d, 2H, Aromatic-H), 7.67(d, 2H, Aromatic-H)
13C-NMR(D2O, 100 MHz)δ ppm: 16(CH3), 23(Aromatic-CH3), 25(CH2), 28(CH2), 30(CH2), 31(CH2), 34(CH2), 37(CH2), 50(CH2), 69(OCH2), 128(Aromatic), 132(Aromatic), 142(Aromatic), 145(Aromatic), 178(COO), 207(C=O)
元素分析値:C11H21NO3・C7H8SO3として
理論値:C 55.79%; H 7.54%; N 3.61%
実測値:C 55.1%; H 7.3%; N 3.6%
Example 2 Preparation of 5-aminolevulinic acid hexyl ester p-toluenesulfonate 50-66 mg (1.64 mmol) of 5-aminolevulinic acid p-toluenesulfonate and 1.9 mg (0.01 mmol) of p-toluenesulfonic acid monohydrate In addition to 3 mL of n-hexanol, the mixture was stirred at 80 ° C. for 16 hours. After cooling the reaction solution, 20 mL of cyclohexane was added and stirred, and allowed to stand at 4 ° C. for 18 hours. The precipitated crystals were collected by filtration and dried under reduced pressure at room temperature to obtain 520.4 mg (1.34 mmol) of the desired product. Recovery rate 82 mol%.
1 H-NMR (D 2 O, 400 MHz) δ ppm: 0.85 (t, 3H, CH 3 ), 1.28 (s, 6H, 3CH 2 ), 1.59 (t, 2H, CH 2 ), 2.37 (s, 3H , Aromatic-CH 3 ), 2.65 (t, 2H, CH 2 ), 2.86 (t, 2H, CH 2 ), 4.07 (t, 4H, 2CH 2 ), 7.34 (d, 2H, Aromatic-H), 7.67 ( d, 2H, Aromatic-H)
13 C-NMR (D 2 O, 100 MHz) δ ppm: 16 (CH 3 ), 23 (Aromatic-CH 3 ), 25 (CH 2 ), 28 (CH 2 ), 30 (CH 2 ), 31 (CH 2 ), 34 (CH 2 ), 37 (CH 2 ), 50 (CH 2 ), 69 (OCH 2 ), 128 (Aromatic), 132 (Aromatic), 142 (Aromatic), 145 (Aromatic), 178 (COO ), 207 (C = O)
Elemental analysis value: C 11 H 21 NO 3 · C 7 H 8 SO 3 Theoretical value: C 55.79%; H 7.54%; N 3.61%
Found: C 55.1%; H 7.3%; N 3.6%
実施例3 5−アミノレブリン酸ベンジルエステルp−トルエンスルホン酸塩の製造
5−アミノレブリン酸p−トルエンスルホン酸塩502.8 mg(1.64 mmol)とp−トルエンスルホン酸一水和物1.9 mg(0.01 mmol)をベンジルアルコール3mLに加え、80 ℃で16時間攪拌した。反応液を冷却した後、シクロヘキサン20 mLを加えて攪拌し、4℃で18時間静置した。析出した結晶をろ過回収し、室温下で減圧乾燥した後、目的物494.5 mg(1.26 mmol)を得た。回収率77 mol%。
1H-NMR(D2O, 400 MHz)δ ppm:2.35(s, 3H, CH3), 2.70(t, 2H, CH2), 2.86(t, 2H, CH2), 4.06(s, 2H, CH2), 5.11(s, 2H, OCH2), 7.32(d, 2H, Aromatic-H), 7.38-7.42(m, 5H, Aromatic-H), 7.67(d, 2H, Aromatic-H)
13C-NMR(D2O, 100 MHz)δ ppm: 23(CH3), 30(CH2), 37(CH2), 50(CH2), 70(OCH2), 128(Aromatic), 131.2(Aromatic), 131.6(Aromatic), 131.7(Aromatic), 132(Aromatic), 138(Aromatic), 142(Aromatic), 145(Aromatic), 177(COO), 207(C=O)
元素分析値:C12H15NO3・C7H8SO3として
理論値:C 58.00%; H 5.89%; N 3.56%
実測値:C 57.2%; H 5.9%; N 3.4%
Example 3 Preparation of 5-aminolevulinic acid benzyl ester p-toluenesulfonate 5-aminolevulinic acid p-toluenesulfonate 502.8 mg (1.64 mmol) and p-toluenesulfonic acid monohydrate 1.9 mg (0.01 mmol) The mixture was added to 3 mL of benzyl alcohol and stirred at 80 ° C. for 16 hours. After cooling the reaction solution, 20 mL of cyclohexane was added and stirred, and allowed to stand at 4 ° C. for 18 hours. The precipitated crystals were collected by filtration and dried under reduced pressure at room temperature to obtain 494.5 mg (1.26 mmol) of the desired product. Recovery rate 77 mol%.
1 H-NMR (D 2 O, 400 MHz) δ ppm: 2.35 (s, 3H, CH 3 ), 2.70 (t, 2H, CH 2 ), 2.86 (t, 2H, CH 2 ), 4.06 (s, 2H , CH 2 ), 5.11 (s, 2H, OCH 2 ), 7.32 (d, 2H, Aromatic-H), 7.38-7.42 (m, 5H, Aromatic-H), 7.67 (d, 2H, Aromatic-H)
13 C-NMR (D 2 O, 100 MHz) δ ppm: 23 (CH 3 ), 30 (CH 2 ), 37 (CH 2 ), 50 (CH 2 ), 70 (OCH 2 ), 128 (Aromatic), 131.2 (Aromatic), 131.6 (Aromatic), 131.7 (Aromatic), 132 (Aromatic), 138 (Aromatic), 142 (Aromatic), 145 (Aromatic), 177 (COO), 207 (C = O)
Elemental analysis value: C 12 H 15 NO 3 · C 7 H 8 SO 3 Theoretical value: C 58.00%; H 5.89%; N 3.56%
Actual value: C 57.2%; H 5.9%; N 3.4%
実施例4 融点測定
セイコーインスツルメンツ社製EXSTAR6000熱分析システム(TG/DTA)を用いて5−アミノレブリン酸エステルp−トルエンスルホン酸塩の各種結晶の融点、及び分解点を測定した。結果を表に示す。比較例として塩酸塩の融点も示す。その結果、塩酸塩をp−トルエンスルホン酸塩にすると耐熱性が向上した。
Example 4 Melting point measurement Melting point and decomposition point of various crystals of 5-aminolevulinic acid ester p-toluenesulfonate were measured using EXSTAR6000 thermal analysis system (TG / DTA) manufactured by Seiko Instruments Inc. The results are shown in the table. As a comparative example, the melting point of hydrochloride is also shown. As a result, when the hydrochloride was changed to p-toluenesulfonate, the heat resistance was improved.
実施例5 植物活力効果
内径12cmの磁気性ポットに畑土壌を600g充填し、はつか大根の種子を12粒播種して5mm覆土し、温室内で育成させた。1日1回表記の散布液による茎葉散布処理を行った。21日後の葉の様子を観察した。その結果を表2にまとめた。その結果、5−アミノレブリン酸エステルスルホン酸塩は、5−アミノレブリン酸スルホン酸塩と同等の植物活力効果を示した。
Example 5 Plant vitality effect 600 g of field soil was filled in a magnetic pot having an inner diameter of 12 cm, 12 seeds of radish were sown, covered with 5 mm, and grown in a greenhouse. The foliage spraying treatment with the spray liquid described once a day was performed. The state of the leaves after 21 days was observed. The results are summarized in Table 2. As a result, 5-aminolevulinic acid ester sulfonate showed a plant vitality effect equivalent to 5-aminolevulinic acid sulfonate.
Claims (1)
R1OCOCH2CH2COCH2NH2・HOSO2R2 (1)
〔式中、R1は、ヒドロキシ、アルコキシ、アシルオキシ、アルコキシカルボニルオキシ、アミノ、アリール、オキソ、フロロ、クロロ及びニトロから選ばれる基が置換していてもよい炭化水素基を示し、;R 2 は4−メチルフェニル基を示す。〕
で表される5−アミノレブリン酸エステルp−トルエンスルホン酸塩を含有する植物活力剤組成物。 The following general formula (1)
R 1 OCOCH 2 CH 2 COCH 2 NH 2 · HOSO 2 R 2 (1)
[In the formula, R 1 represents hydroxy, alkoxy, acyloxy, alkoxycarbonyloxy, amino, aryl, oxo, fluoro, chloro and hydrocarbon group which may group selected from nitro substituted by,; R 2 is 4-methylphenyl group is shown . ]
The plant vitality agent composition containing 5-aminolevulinic acid ester p-toluenesulfonate represented by these .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005195942A JP4934293B2 (en) | 2005-07-05 | 2005-07-05 | Plant vitality composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005195942A JP4934293B2 (en) | 2005-07-05 | 2005-07-05 | Plant vitality composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007015938A JP2007015938A (en) | 2007-01-25 |
JP4934293B2 true JP4934293B2 (en) | 2012-05-16 |
Family
ID=37753414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005195942A Active JP4934293B2 (en) | 2005-07-05 | 2005-07-05 | Plant vitality composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4934293B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9645154B2 (en) | 2010-12-24 | 2017-05-09 | Arkray, Inc. | Method for detecting cancer cell |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2394642A1 (en) * | 2010-06-10 | 2011-12-14 | Universite De Geneve | 5-ALA ester formulations and use thereof |
WO2013005379A1 (en) | 2011-07-01 | 2013-01-10 | Sbiファーマ株式会社 | Photodynamic therapy using photosensitizing agent or 5-aminolevulinic acid |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2767318B2 (en) * | 1990-04-11 | 1998-06-18 | 株式会社コスモ総合研究所 | 5-Aminolevulinic acid alkyl ester or salt thereof, process for producing the same, and herbicide containing the same as active ingredient |
JPH04217650A (en) * | 1990-10-29 | 1992-08-07 | Japan Tobacco Inc | Production of acid addition salt of delta-amino-levulinic acid |
JP2613136B2 (en) * | 1991-05-14 | 1997-05-21 | 株式会社コスモ総合研究所 | Plant growth promoter |
JP2997979B2 (en) * | 1993-01-20 | 2000-01-11 | 株式会社コスモ総合研究所 | Method for producing 5-aminolevulinic acid |
JP2747644B2 (en) * | 1993-08-19 | 1998-05-06 | 株式会社コスモ総合研究所 | Plant growth regulator |
JP2887555B2 (en) * | 1993-08-19 | 1999-04-26 | 株式会社コスモ総合研究所 | Nitrate nitrogen content reducing agent for plants |
JP2896963B2 (en) * | 1994-11-28 | 1999-05-31 | 株式会社コスモ総合研究所 | Plant salt tolerance improver |
US5945564A (en) * | 1995-07-12 | 1999-08-31 | Mitsubishi Chemical Corporation | 2,2-dideutero-5-aminolevulinic acid |
JPH1112197A (en) * | 1997-06-18 | 1999-01-19 | Cosmo Sogo Kenkyusho:Kk | Malignant tumor diagnostic agent and therapeutic agent |
JP2001000010A (en) * | 1999-06-21 | 2001-01-09 | Kumiai Chem Ind Co Ltd | Agent for treating seed of plant and method for treating seed |
GB0018528D0 (en) * | 2000-07-27 | 2000-09-13 | Photocure Asa | Compounds |
GB0018527D0 (en) * | 2000-07-27 | 2000-09-13 | Photocure Asa | Composition |
EP1545484A4 (en) * | 2002-10-05 | 2010-01-13 | Hanmi Pharm Ind Co Ltd | Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate |
GB0406917D0 (en) * | 2004-03-26 | 2004-04-28 | Photocure Asa | Compounds |
-
2005
- 2005-07-05 JP JP2005195942A patent/JP4934293B2/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9645154B2 (en) | 2010-12-24 | 2017-05-09 | Arkray, Inc. | Method for detecting cancer cell |
Also Published As
Publication number | Publication date |
---|---|
JP2007015938A (en) | 2007-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101514659B1 (en) | Processes for the synthesis of diarylthiohydantoin and diarylhydantoin compounds | |
JP6910551B2 (en) | Photosensitizers, their derivatives and applications | |
JP4417865B2 (en) | 5-Aminolevulinic acid phosphate, method for producing the same, and use thereof | |
JP2017160243A (en) | Crystals of 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidin-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | |
CN1649582A (en) | Amino-methyl substituted tetracycline compounds | |
WO2005100300A1 (en) | 5-aminolevulinic acid salt, process for producing the same and use thereof | |
KR101131703B1 (en) | Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof | |
JP4934293B2 (en) | Plant vitality composition | |
WO2018144620A1 (en) | Anti-fibrotic compounds | |
JP4934292B2 (en) | 5-Aminolevulinic acid ester phosphoric acid salts, method for producing the same, and use thereof | |
JP2005314360A (en) | 5-aminolevulinic acid sulfonate and its manufacturing method | |
CA2987879A1 (en) | Aqueous drug | |
JP6843116B2 (en) | Crystal form of androgen receptor inhibitor and its production method | |
CN1317265C (en) | Cyanoacrylate derivatives and their preparation method and biological activity | |
RU2011128393A (en) | CRYSTALLINE FORMS OF COMPOUND 3-CARBOXYPROPYL-AMINOTETRALIN | |
JP4915723B2 (en) | Method for producing amino acid phosphates | |
US11905250B2 (en) | Methods for preparation of jasmonate compounds | |
JP2013532723A (en) | Novel Montelukast 4-halobenzylamine salt and method for producing Montelukast sodium salt using the same | |
JP6040079B2 (en) | Method for producing amide derivative | |
AU2017387801B2 (en) | Methods for the preparation of 6-aminoisoquinoline | |
RU2374238C1 (en) | Alpha-crystalline form of substituted selenoxanthenes and method of producing said form | |
JP4616168B2 (en) | (2S, 3S) -3-[[(1S) -1-isobutoxymethyl-3-methylbutyl] carbamoyl] oxirane-2-carboxylic acid salt | |
WO2012081036A2 (en) | A process for preparation of 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione) | |
CN1642959A (en) | Novel dithiolopyrrolones with therapeutic activity | |
ES2807558T3 (en) | Procedure for preparing oxathiazine-type compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080304 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110420 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110426 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110621 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120214 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120220 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4934293 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150224 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |